Bahl & Gaynor’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-9,189
Closed -$896K 353
2019
Q2
$896K Sell
9,189
-50
-0.5% -$4.87K 0.01% 280
2019
Q1
$931K Sell
9,239
-200
-2% -$17.8K 0.01% 272
2018
Q4
$770K Sell
9,439
-640
-6% -$58.2K 0.01% 269
2018
Q3
$994K Sell
10,079
-12
-0.1% -$1.27K 0.01% 268
2018
Q2
$1.09M Buy
10,091
+20
+0.2% +$2.15K 0.01% 263
2018
Q1
$1.05M Buy
10,071
+50
+0.5% +$5.81K 0.01% 275
2017
Q4
$1.18M Buy
10,021
+61
+0.6% +$6.32K 0.01% 265
2017
Q3
$984K Sell
9,960
-156
-2% -$13.9K 0.01% 265
2017
Q2
$900K Sell
10,116
-984
-9% -$86.6K 0.01% 275
2017
Q1
$997K Buy
11,100
+277
+3% +$23.9K 0.01% 254
2016
Q4
$935K Buy
10,823
+450
+4% +$40.2K 0.01% 251
2016
Q3
$899K Buy
10,373
+4,804
+86% +$482K 0.01% 253
2016
Q2
$593K Buy
5,569
+153
+3% +$15.8K 0.01% 294
2016
Q1
$570K Buy
5,416
+571
+12% +$54.7K 0.01% 296
2015
Q4
$431K Sell
4,845
-16
-0.3% -$1.43K 0.01% 330
2015
Q3
$441K Buy
+4,861
New +$487K 0.01% 328

Other funds holding CRI

Bahl & Gaynor's CRI Position: Q3 2019 in Review

Bahl & Gaynor sold out of Carter's (CRI) in Q3 2019, closing a stake of 9,189 shares — an estimated $896K sold.

Bahl & Gaynor first reported a position in CRI in Q3 2015 and held it in 16 quarters. The position peaked at $1.18M in Q4 2017. 285 funds tracked by Wall St. Rank hold CRI as of Q3 2019.

  • Bahl & Gaynor reported no remaining Carter's position as of Q3 2019 after selling out during the quarter.
  • Bahl & Gaynor sold 9,189 Carter's shares in Q3 2019, an estimated $896K.
  • Bahl & Gaynor first reported a position in Carter's in Q3 2015 and held it in 16 quarters.
  • Bahl & Gaynor's Carter's position peaked at $1.18M in Q4 2017.
  • 285 funds tracked by Wall St. Rank held Carter's as of Q3 2019.

Based on Bahl & Gaynor's 13F filing for Q3 2019, filed 14 Nov 2019.